Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Digestive System Neoplasms × olaparib × Clear all

Sponsor

Conditions

Ovarian Neoplasms 19 Breast Neoplasms 10 Prostatic Neoplasms 9 Triple Negative Breast Neoplasms 7 Fallopian Tube Neoplasms 7 Neoplasm Metastasis 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Stomach Neoplasms 3 Small Cell Lung Carcinoma 3 Sarcoma 3 Neoplasms 3 Metastatic Castration-resistant Prostate Cancer 3 Fanconi Anemia, Complementation Group D1 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Pancreatic Neoplasms 2 Endometrial Neoplasms 2 Castration-Resistant Prostate Carcinoma 2 Carcinoma 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Prostate 1 Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma 1 Peritoneal Neoplasms 1

Interventions

Gemcitabine 5 Irinotecan 4 130-nm albumin-bound paclitaxel 4 Albumin-Bound Paclitaxel 3 napabucasin 2 Leucovorin 2 Imatinib Mesylate 2 Everolimus 2 Cisplatin 2 Ascorbic Acid 2 spartalizumab 1 pralsetinib 1 pembrolizumab 1 dostarlimab 1 copanlisib 1 alectinib 1 Ramucirumab 1 Paclitaxel 1 Levoleucovorin 1 KRN-330 1 HhAntag691 1 Fluorouracil 1 Cyclophosphamide 1 Capecitabine 1 Bevacizumab 1 5,10-methylenetetrahydrofolic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡